organic compounds
JP7856707B2Active Publication Date: 2026-05-11INTRA CELLULAR THERAPIES INC
View PDF 1 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- INTRA CELLULAR THERAPIES INC
- Filing Date
- 2024-08-21
- Publication Date
- 2026-05-11
Smart Images

Figure 0007856707000057 
Figure 0007856707000058 
Figure 0007856707000059
Abstract
To provide immune system cells including macrophages and microglia, and pharmaceuticals for suppressing recruitment of other cells to cancer.SOLUTION: The present invention provides a pharmaceutical for suppressing macrophage or microglial recruitment to metastatic cells, comprising a PDE1 inhibitor. Preferably, the pharmaceutical is administered in combination with a checkpoint inhibitor. Preferably, the checkpoint inhibitor is an inhibitor of CTLA-4, PD-1 and / or PD-L1.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art